Panelist, " Exiting Today: Options, Key Considerations & What Can Be Learned From Past Exits?," IMN's Sixth Annual New York Non-Traded REIT Industry Symposium
This event has already occurred.
Related Insights
AI and the Importance of Trade Secrets and Confidentiality
Shutdown Updates, FDA Orphan Drug Leader Reassigned as CMS Issues Orphan Drugs Guidance, FDA to Host Allergen Threshold Meeting, and Commissioner’s National Priority Review Vouchers